3M (MMM) vs Solventum (SOLV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Solventum (SOLV) has outperformed 3M (MMM) over the past year, gaining 19.0% versus a gain of 4.4%. 3M is the larger company by market cap ($82.96 billion vs $14.63 billion), about 5.7 times the size. On valuation, Solventum trades at a lower forward P/E (11.9x vs 16.4x for 3M).
3M pays a dividend yielding 1.88%, while Solventum does not currently pay one. Solventum converts more of its revenue into profit, with a net margin of 18.7% versus 13.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MMM | SOLV |
|---|---|---|
| Share price | $160.86 | $85.95 |
| Market cap | $82.96B | $14.63B |
| 1-day change | -0.78% | +0.08% |
| YTD return | +1.26% | +8.38% |
| 1-year return | +4.37% | +19.01% |
| 5-year return | +6.57% | — |
| P/E ratio (TTM) | 28.57 | 10.52 |
| Forward P/E | 16.37 | 11.89 |
| EPS (TTM) | $5.63 | $8.17 |
| Dividend yield | 1.88% | 0.00% |
| Annual dividend | $3.02 | $0.00 |
| Revenue (latest FY) | $24.95B | $8.32B |
| Revenue growth (YoY) | +1.52% | +0.86% |
| Net income (latest FY) | $3.25B | $1.56B |
| Gross margin | 39.91% | 53.47% |
| Operating margin | 18.55% | 26.20% |
| Net margin | 13.03% | 18.69% |
| 52-week high | $184.90 | $94.16 |
| 52-week low | $139.34 | $62.38 |
| Distance from 52-week high | -13.00% | -8.72% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +16.41% | +9.73% |
| Average volume | 3.17M | 1.02M |
| Shares outstanding | 515.72M | 170.22M |
| Employees | 60,500 | 20,584 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- 3M is about 5.7 times larger than Solventum by market value ($82.96B vs $14.63B).
- SOLV has outperformed MMM by 14.6 percentage points over the past year.
- 3M trades at a higher earnings multiple (28.6x vs 10.5x trailing P/E).
- 3M offers a meaningfully higher dividend yield (1.88% vs 0.00%).
- Solventum is more profitable, keeping 18.7 cents of every revenue dollar as net income versus 13.0 cents for 3M.
About 3M
MMM stock →3M Company provides diversified technology services in the America, the Asia Pacific, Europe, the Middle East, Africa, and internationally. It operates through three segments: Safety and Industrial, Transportation and Electronics, and Consumer.
Health Care · Medical/Dental Instruments · 60,500 employees
About Solventum
SOLV stock →Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems.
Health Care · Medical/Dental Instruments · 20,584 employees
MMM vs SOLV FAQ
Which is bigger, 3M or Solventum?
3M (MMM) is larger, with a market capitalization of $82.96B compared with $14.63B for Solventum (SOLV).
Which stock has performed better over the past year, MMM or SOLV?
SOLV returned +19.01% over the past 12 months, compared with +4.37% for MMM (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, MMM or SOLV?
SOLV has the lower trailing P/E at 10.5, versus 28.6 for MMM. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, 3M or Solventum?
3M pays a dividend yielding 1.88%, while Solventum does not currently pay a regular dividend.
Are 3M and Solventum in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.